Document is current
Any future updates will be listed below
-
Authors
Asken, Breton M.
Tanner, Jeremy A.
Gaynor, Leslie S.
VandeVrede, Lawren
Mantyh, William G.
Casaletto, Kaitlin B.
Staffaroni, Adam M.
Fonseca, Corrina
Shankar, Ranjani
Grant, Harli
Smith, Karen
Lago, Argentina Lario
Xu, Haiyan
La Joie, Renaud
Cobigo, Yann
Rosen, Howie
Perry, David C.
Rojas, Julio C.
Miller, Bruce L.
Gardner, Raquel C.
Wang, Kevin K. W.
Kramer, Joel H.
Rabinovici, Gil D.
- License Information
-
More Information
Article History
Received: 6 May 2023
Accepted: 12 July 2023
First Online: 21 July 2023
Declarations
:
: All study procedures were reviewed and approved by the UCSF institutional review board (IRB-01) and participants provided informed consent prior to participation.
: Not applicable.
: AMS has served as a consultant for Passage Bio and Takeda. JHK has provided consultation to Biogen. GDR receives research funding from Avid Radiopharmaceuticals, GE Healthcare, Genentech, Life Molecular Imaging, and has served as consultant for Alector, Eli Lilly, Genentech, GE Healthcare, Roche, Johnson & Johnson, and Merck, and is an Associate Editor for JAMA Neurology. WGM has served as a consultant for Genentech/Roche. KKWW is a shareholder of Gryphon Bio, Inc.
